News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
246 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (119)
3 (12)
4 (242)
5 (269)
6 (241)
7 (243)
8 (78)
9 (2)
10 (3)
11 (232)
12 (312)
13 (213)
14 (243)
15 (110)
16 (8)
17 (9)
18 (85)
19 (267)
20 (246)
21 (243)
22 (113)
23 (7)
24 (12)
25 (220)
26 (276)
27 (239)
28 (312)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
Medtronic Announces Cash Tender Offer for Certain Outstanding Debt Securities Issued by Medtronic, Inc. and Covidien International Finance S.A.
Medtronic plc announced the commencement of a cash tender offer by its indirectly wholly owned subsidiaries
February 20, 2019
·
12 min read
Deals
Invitation to Presentation of Promore Pharma’s Year-end report for 2018
Promore Pharma AB (publ) publishes its Year-end report for 2018 at 09.00 CET on 26 February 2019
February 20, 2019
·
1 min read
Policy
FDA Cracks Down on Unauthorized Use of Plasma Treatments for Aging, Other Illnesses
In the seventeenth century, Hungarian Countess Elizabeth Bathory bathed in the blood of young women she murdered in order to sustain her beauty. Blood, albeit more freely given, continues to be an attractive tool for some who want to stave off the effects of age.
February 20, 2019
·
2 min read
·
Alex Keown
Job Trends
Seattle Area Life Science Employment Rebounds After Some Big Departures
Since Amgen shut down its Bothell, Wash. site in 2014, life science employment growth has increased 13 percent across the state. According to The Seattle Times, companies across the region are in a scaling up process.
February 20, 2019
·
3 min read
·
Alex Keown
Job Trends
Study finds melanoma brain metastases are immunosuppressive with treatment-resistant metabolism
Research shows deadly tumors may be vulnerable to drugs that block their energy supply
February 20, 2019
·
7 min read
Business
Medtronic EVP & RTG President Geoff Martha to Speak at Leerink Partners Global Healthcare Conference
Medtronic plc, the global leader in medical technology, announced it will participate in the 8th Annual Leerink Partners Global Healthcare Conference in New York.
February 20, 2019
·
1 min read
Business
Evotec And Helmholtz Centre Joining Platforms And Forces For Novel Antibiotics
Evotec and helmholtz aim to jointly develop cystobactamid derivatives into a new class of broad spectrum antiobiotics targeting high-priority pathogens
February 20, 2019
·
5 min read
Promising Interim Results From Tavr Animal Study
Medical technology company Admedus Ltd is pleased to advise that interim data from the animal study of its single-piece 3D aortic valve suggest that the device can be implanted safely and has the potential to deliver meaningful clinical benefits.
February 20, 2019
·
1 min read
Business
ICON Reports Fourth Quarter and Full Year 2018 Results
2019 outlook reaffirmed with revenue guidance in the range of $2,735 - $2,835 million and earnings per share guidance in the range of $6.69 – $6.89 a year over year increase of 9.9% - 13.1%.
February 20, 2019
·
12 min read
Business
Cold Rescue Elements the Perfect Antidote to the Winter Cold Season
The cold season, which begins in late August and continues until March or April, may be due to schools opening, the colder weather or just because people spend more time indoors.
February 20, 2019
·
2 min read
Previous
2 of 25
Next